Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases

Bibliography

• MILENIC DE, BRADY ED, BRECHBIEL MW: Antibody-targeted radiation cancer therapy. Nature Rev Drug Discovery (2004) 3:488–498.
   Google Scholar
• ••A detailed overview of the current state ofcancer RIT
   Google Scholar
• STILLWAGON GB, KLEIN JL et al: Iodine 131-antiferritin, a new treatment modality in hepatoma: a Radiation Oncology Group study. I Clin. Oncol (1985) 3:1573–1582.
   Google Scholar
• •This paper describes the first RIT clinical trial in cancer patients.
   Google Scholar
• KAMINSKI MS, TUCK M, ESTES J et al: 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl. J. Med. (2005) 352:441–449.
   Google Scholar
• ••This article suggests the use of RIT as thefirst-line therapy for non-Hodgkin's lymphoma.
   Google Scholar
• CASADEVALL A, DADACHOVA E, PIROFSKI L: Passive antibody therapy for infectious diseases. Nat. Rev Microbial. (2004) 2:695–703.
   Google Scholar
• •This paper presents a historical perspective and summarises the current state of passive antibody therapy of infectious diseases.
   Google Scholar
• DADACHOVA E, NAKOUZI A, BRYAN R, CASADEVALL A: Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc. Nati Acad. Sci. USA (2003) 100:10942–10947.
   Google Scholar
• ••A proof-of-principle paper, showing theapplicability of the RIT approach to the treatment of infectious diseases.
   Google Scholar
• DADACHOVA E, BRYAN RA, FRENKEL A et al.: Evaluation of acute hematological and long-term pulmonary toxicity of radioimmunotherapy of Cryptococcus neoformans infection in murine models. Antimicrob. Agents Chemother. (2004) 48:1004–1006.
   Google Scholar
• DADACHOVA E, HOWELL RW, BRYAN RA, FRENKEL A, NOSANCHUK JD, CASADEVALL A: Susceptibility of human pathogens Cryptococcus neoformans and Histoplasma capsulatum to gamma radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. J. Nucl. Med. (2004) 45:313–320.
   Google Scholar
• DADACHOVA E, BURNS T, BRYAN RA et al.: Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob. Agents Chemother. (2004) 48:1624–1629.
   Google Scholar
• KNOX SJ, MEREDITH RF: Clinical radioimmunotherapy. Semin. Radiat. Oncol (2000) 10:73–93.
   Google Scholar
• MILENIC DE: Radioimmunotherapy: designer molecules to potentiate effective therapy. Smith. Radial-. Oncol (2000) 10:139–155.
   Google Scholar
• BUCHSBAUM DJ: Experimental radioimmunotherapy. Semin. Radiat. Oncol (2000) 10:156–167.
   Google Scholar
• VIEIRA P, RAJEWSKY K: The half-lives of serum immunoglobulins in adult mice. Eur. Immunol (1988) 18:313–316.
   Google Scholar
• IZNAGA-ESCOBAR N, MISHRA AK, PEREZ-RODRIGUEZ R: Factors affecting pharmacokinetics of monoclonal antibodies. Methods Find. Exp. Clin. Pharmacol (2004) 26:123–127.
   Google Scholar
• BECKER W: The contribution of nuclearmedicine to the patient with infection. Eur. Nucl. Med. (1995) 22:1195–1211.
   Google Scholar
• RENNEN HJ, MAKAREWICZ J, OYEN WJ, LAVERMAN P, CORSTENS FH, BOERMAN OC: The effect of molecular weight on nonspecific accumulation of (99m)Tc-labeled proteins in inflammatory foci. Nucl. Med. Biol. (2001) 28:401–408.
   Google Scholar
• LINDMO T, BOVEN E, CUTTITTA F, ORKO J, BUNN PA Jr: Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. Immunol Methods (1984) 72:77–89.
   Google Scholar
• MILENIC DE, YOKOTA T, FILPULA DR et al: Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. (1991) 51:6363–6371.
   Google Scholar
• SLAVIN-CHIORINI DC, KASHMIRI SV, LEE HS et al: A CDR-grafted (humanized) domain-deleted antitumor antibody. Cancer Biother. Radiopharm. (1997) 12:305–316.
   Google Scholar
• MILENIC D, GARMESTANI K, DADACHOVA E et al: Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother. Radiopharm. (2004) 19:135–147.
   Google Scholar
• CASADEVALL A, MUKHERJEE J, DEVI SJ, SCHNEERSON R, ROBBINS JB, SCHARFF MD: Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. (1992) 165:1086–1093.
   Google Scholar
• PAGANELLI G, GRANA C, CHINOL M et al.: Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur. Nucl. Med. (1999) 26:348–357.
   Google Scholar
• CHEN JQ, STRAND SE, TENNVALL J, LINDGREN L, HINDORF C, SJOGREN HO: Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96. Nucl. Med. (1997) 38(12):1934–1939.
   Google Scholar
• DIENHART DG, KASLIWAL R, LEAR JL et al.: Extracorporeal immunoadsorption of radiolabelled monoclonal antibody: a method of reduction of background radioactivity and its potential role during the radioimmunotherapy of cancer. Antibody Immunoconj. Radiopharm. (1994) 7:225–252.
   Google Scholar
• POULAIN D, DEVEAUX M, CAILLIEZ JC et al.: Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: experimental study in the guinea pig. Int. J. Rad. Appl. Instrum. B. (1991) 18(7):677–686.
   Google Scholar
• RUBIN RH, YOUNG LS, HANSEN WP et al.: Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J. Nucl. Med. (1988) 29(5):651–656.
   Google Scholar
• HAZRA DK, LAHIRI VL, SARAN S et al.:In vivo tuberculoma creation and its radioimmunoimaging. Nucl. Med. Commun. (1987) 8(3):139–142.
   Google Scholar
• MALPANI BL, KADIVAL GV, SAMUEL AM: Radioimmunoscintigraphic approach for the in vitro detection of tuberculomas - a preliminary study in a rabbit model. Nucl. Med. Biol. (1992) 19:45–53.
   Google Scholar
• HUANG JT, RAISZADEH M, SAKIMURA I, MONTGOMERIE JZ, HARWIG JF: Detection of bacterial endocarditis with technetium-99m-labeled antistaphylococcal antibody../. Nucl. Med. (1980) 21(8):783–786.
   Google Scholar
• GOLDMAN DL, CASADEVALL A, ZUCKIER LS: Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. I Med. Vet. Mycol. (1997) 35:271–278.
   Google Scholar
• GOLDENBERG DM, SHARKEY RM, UDEM S et al: Immunoscintigraphy of Pneumocystis carirdi pneumonia in AIDS patients../. Nucl. Med. (1994) 35:1028–1034.
   Google Scholar
• ••This article shows the applicability of radiolabelled organism-specific antibodies for the diagnosis of infection in patients.
   Google Scholar
• MURTHA AD: Review of low-dose-rate radiobiology for clinicians. Semi]. Radiation Oncol (2000) 10:133–138.
   Google Scholar
• KNOX SJ, GORIS ML, WESSELS BW: Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam radiation. Radiother. Oncol (1992) 23:111–117.
   Google Scholar
• XUE LY, BUTLER NJ, MAKRIGIORGOS GM, ADELSTEIN SJ, KASSIS AI: Bystander effect produced by radiolabeled tumor cells in vivo. Proc. Nati Acad. Sci. USA (2002) 99:13765–13770.
   Google Scholar
• BISHAYEE A, RAO DV, HOWELL RW: Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radial-. Res. (1999) 152:88–97.
   Google Scholar
• TABORDA CP, CASADEVALL A: Immunoglobulin M efficacy against Cryptococcus neoformans mechanism, dose dependence, and prozone-like effects in passive protection experiments. Immunol. (2001) 166:2100–2107.
   Google Scholar
• WHELDON TE: Targeting radiation totumours. Int. J. Radial-. Biol. (1994) 65:109–116.
   Google Scholar
• MAUSNER LF, SRIVASTAVA SC: Selection of radionuclides for radioimmunotherapy. Med. Phys. (1993) 20:503–509.
   Google Scholar
• SHARKEY RM, GOLDENBERG D: Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J. Nucl. Med. (2005) 46\(Suppl. 1):115S–127S.
   Google Scholar